Modalis

A biotech company developing therapeutics with epigenetic editing technology, CRISPR-GNDM®

Biotech & Life Sciences

Sector

Seed

Stage

Biotech therapeutics

Model

01Company Overview

A biotech company developing therapeutics with epigenetic editing technology, CRISPR-GNDM®.

02Backed By1 investor

03Similar Companies

SB

Singular Bio

Biotech & Life Sciences

→

MB

C

EB

BT

04Startup DNA

8

signals

Sectors
Business Model
Technology